MedPath

UNIVERSITA' DEGLI STUDI DI CATANIA

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:1
Completed:12

Trial Phases

4 Phases

Phase 1:1
Phase 3:1
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (66.7%)
Phase 4
2 (16.7%)
Phase 1
1 (8.3%)
Phase 3
1 (8.3%)

Study of the Vaginal Microbiota in Women Under Fertile Age

Completed
Conditions
Vaginal Disease
First Posted Date
2023-04-18
Last Posted Date
2023-04-18
Lead Sponsor
Universita degli Studi di Catania
Target Recruit Count
120
Registration Number
NCT05817292
Locations
🇮🇹

University of Catania, Catania, Italy

Personal Vaporizer vs Cigalike

Not Applicable
Completed
Conditions
Cigarette Addiction
First Posted Date
2015-03-25
Last Posted Date
2015-12-02
Lead Sponsor
Universita degli Studi di Catania
Target Recruit Count
200
Registration Number
NCT02398487
Locations
🇮🇹

Centro per la Prevenzione e Cura del Tabagismo University of Catania, Catania, Italy

Smoking Cessation And Reduction in Depression

Not Applicable
Conditions
Tobacco Smoking in Depressed Patients
First Posted Date
2014-04-28
Last Posted Date
2022-05-17
Lead Sponsor
Universita degli Studi di Catania
Target Recruit Count
129
Registration Number
NCT02124187
Locations
🇮🇹

AOU Policlinico - Vittorio Emanuele di Catania, Catania, Sicily, Italy

High Cessation Rates in Smokers Using Personal Vaporizers

Phase 4
Completed
Conditions
Tobacco Addiction
First Posted Date
2014-04-28
Last Posted Date
2014-06-10
Lead Sponsor
Universita degli Studi di Catania
Target Recruit Count
40
Registration Number
NCT02124200
Locations
🇮🇹

1Centro per la Prevenzione e Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", Università di Catania,, Catania, Italy

Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma

Phase 3
Conditions
Low Dose Methotrexate in Severe Chronic Asthma
Interventions
Drug: Placebo
First Posted Date
2014-04-28
Last Posted Date
2021-09-28
Lead Sponsor
Universita degli Studi di Catania
Target Recruit Count
102
Registration Number
NCT02124226
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath